Validated high-performance liquid chromatographic technique for determination of 5-fluorouracil: Applications to stability studies and simulated colonic media

Journal of Chromatographic Science

Volumn 47, Issue 7, 2009, Pages 558-563

  Alanazi, Fars K ^a,b   Yassin, Alaa Eldeen ^a   El Badry, Mahmoud ^a   Mowafy, Hammam A ^a   Alsarra, Ibrahim A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b Kayyali Chair for Pharmaceutical Industry   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

RATTUS;

EID: 70350155119     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/47.7.558     Document Type: Article

References (31)

1. F. Casale, R. Canaparo, L. Serpe, E. Muntoni, C.D. Pepa, M. Costa, L. Mairone, G.P. Zara, G. Fornari, and M. Eandi. Plasma concentrations of 5-fluorouracil and its metabolites in colon cancer patients. Pharm. Res. 50: 173-179 (2004).
2. J.D. Potter. Colorectal cancer: molecules and populations. J. Natl. Cancer Inst. 91: 916-932 (1999).
3. G. Micoli, R. Turci, M. Arpellini, and C. Minoia. Determination of5-fluorouracil in environmental samples by solid-phase extraction and high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. B Biomed. Sci. Appl. 750: 25-32 (2001).
4. Y.S. Krishnaiah, V. Satyanarayana, B. Dinesh Kumar, and R.S. Karthikeyan. In vitro drug release studies on guar gum-based colon targeted oral drug delivery systems of 5-fluorouracil. Eur. J. Pharm. Sci. 16: 185-192 (2002).
5. M.B. Garg, J.C. Sevester, J.A. Sakoff, and S.P. Ackland. Simple liquid chromatographic method for the determination of uracil and dihydrouracil plasma levels: a potential pretreatment predictor of 5-flurouracil toxicity. J. Chromatogr. B Biomed. Sci. Appl. 774: 223-230 (2002).
6. E.A. de Bruijn, O. Driessen, N. van den Bosch, E. van Strijen, P.H. Slee, A.T. van Oosterom, and U.R. Tjaden. A gas chromato-graphic assay for the determination of 5,6-dihydrofluorouracil and 5-fluorouracil in human plasma. J. Chromatogr. 278: 283-289 (1983).
7. R.G. Hahn, C.G. Moertel, A.J. Schutt, and H.W. Bruckner. A double-blind comparison of intensive course 5-fluorouracil by oral vs. intravenous route in the treatment of colorectal carcinoma. Cancer 35: 1031-1035 (1975).
8. T. Minko. Drug targeting to the colon with lectins and neoglyco-conjugates. Adv. Drug Delivery Rev. 56: 491-509 (2004).
9. M.K. Chourasia and S.K. Jain. Polysaccharides for colon targeted drug delivery. Drug Deliv. 11: 129-148 (2004).
10. L. Liu, M.L. Fishman, J. Kost, and K.B. Hicks. Pectin-based systems for colon-specific drug delivery via oral route. Biomaterials 24: 3333-3343 (2003).
11. M.K. Chourasia and S.K. Jain. Pharmaceutical approaches to colon targeted drug delivery systems. J. Pharm. Sci. 6: 33-66 (2003).
12. L. Yang, J.S. Chu, and J.A. Fix. Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int. J. Pharm. 235: 1-15 (2002).
13. D. Anderson, D.J. Kerr, C. Blesing, and L.W. Seymour. Simultaneous gas chromatographic-mass spectrophotometric determination of alpha-fluoro-beta-alanine and 5-fluorouracil in plasma. J. Chromatogr. B Biomed. Sci. Appl. 688: 87-93 (1997).
14. M. Barberi-Heyob, J.L. Merlin, and B. Weber. Analysis of 5-fluo-rouracil in plasma and urine by high-performance liquid chromatography. J. Chromatogr. 581: 281-286 (1992).
15. F. Bressolle, M. Bromet-Petit, and M. Audran. Validation of liquid chromatographic and gas chromatographic methods. Applications to pharmacokinetics. J. Chromatogr. B Biomed. Appl. 686: 3-10 (1996).
16. R. Causon. Validation of chromatographic methods in biomedical analysis. Viewpoint and discussion. J. Chromatogr. B Biomed. Appl. 689: 175-180 (1997).
17. ICH. Stability Testing of New Drug Substances and Products Q1A (R2), International Conference on Harmonization, IFPMA, Geneva, 2003.
18. H. Lamprecht, H. Yamamoto, Y. Takeuchi, and Y. Kawashima. Microsphere design for the colonic delivery of 5-fluorouracil. J. Controlled Release 90: 313-322 (2003).
19. A. Paharia, K. Yadav, G. Rai, S.K. Jain, S.S. Pancholi, and G.P. Agrawal. Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting. AAPS PharmSciTech 8: E1-E7 (2007).
20. V.R. Sinha, B.R. Mittal, K.K. Bhutani, and R. Kumria. Colonic drug delivery of 5-fluorouracil: an in vitro evaluation. Int. J. Pharm. 269: 101-108 (2004).
21. Y. Zambito, A. Baggiani, V. Carelli, M.F. Serafini, and G. Di Colo. Matrices for site-specific controlled-delivery of 5-fluorouracil to descending colon. J. Controlled Release 102: 669-77 (2005).
22. Food and Drug Administration (FDA), Guidelines for Industry in Bioanalytical Method Validation, Rockville, MD, USA, 2001.
23. M. Bakshi and S. Singh. ICH guidance in practice: establishment of inherent stability of secnidazole and development of a validated stability-indicating high performance liquid chromato-graphic assay method. J. Pharm. Biomed. Anal. 36: 769-775 (2004).
24. P. Compagnon, L. Thiberville, N. Moore, C. Thuillez, and C. Lacroix. Simple high-performance liquid chromatographic method for the quantitation of 5-fluorouracil in human plasma. J. Chromatogr. B 677: 380-383 (1996).
25. S.P. Ackland, M.B. Garg, and R.H. Dunstan. Simultaneous determination of dihydrofluorouracil and 5-fluorouracil in plasma by high-performance liquid chromatography. Anal. Biochem. 256: 79-85 (1997).
26. W.R. Wrighston, S.R. Myers, and S. Galandiuk. HPLC analysis of 5-FU and FdUMP in tissue and serum. Biochem. Biophys. Res. Commun. 22: 808-813 (1995).
27. D.K Bempong and L. Bhattacharyya. Development and valida-tion of a stability-indicating high-performance liquid chromato-graphic assay for ketoprofen topical penetrating gel. J. Chromatogr. A 1073: 341-346 (2005).
28. H.T. Karnes and C. March. Precision, accuracy, and data acceptance criteria in biopharmaceutical analysis. Pharm. Res. 10: 1420-1426 (1993).
29. I.A. Alsarra and M.N. Alarifi. Validated liquid chromatographic determination of 5-fluorouracil in human plasma. J. Chromatogr. B Biomed. Appl. 804: 435-439 (2004).
30. R.A. Fleming and C.F. Stewart. Stability-indicating high-performance liquid chromatographic method for the simultaneous determination of cisplatin and 5-fluorouracil in 0.9% sodium chloride for injection. J. Chromatogr. B Biomed. Sci. Appl. 528: 517-525 (1990).
31. T. Dine, F. Kahlfi, M. Duban, B. Gressier, M. Luyckx, C. Brunet, X. Meersseman, F. Goudaliez, M. Cazin, and J.C. Cazin. Effects of PVC bags sterilization process on the 5-fluorouracil stability. Biomaterials 20: 655-661 (1999).